Brief: Regulus Therapeutics Inc Entered Into A Securities Purchase Agreement On March 11
March 14 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS INC - ON MARCH 11 ENTERED INTO A
SECURITIES PURCHASE AGREEMENT
* REGULUS THERAPEUTICS INC - PURSUANT TO AGREEMENT SOLD AND
ISSUED
45,108,667 SHARES OF COMPANY'S COMMON AT A PURCHASE PRICE OF
$1.60 PER SHARE
Source text for Eikon: ID:n0001193125-24-068000
Further company coverage: RGLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview